Infectious Diseases News Alerts

• Alert Medical Specialties Match Hits Another New High This Year The 2018 medical specialties match set record highs in number of applicants, programs, positions, and positions filled for 2019.
  Medscape Medical News, December 2018
• Alert EC Clears Two New HIV Drugs (Pifeltro and Delstrigo) Pifeltro contains doravirine, a new nonnucleoside reverse transcriptase inhibitor, and Delstrigo is a fixed-dose combination of doravirine, lamivudine, and tenofovir disoproxil fumarate.
  International Approvals, November 2018
• Alert ER Doctor, Pharmacist Among Dead in Chicago Hospital Shooting Doctors unite in mourning on Twitter and vent at the NRA, using #ThisIsOurLane.
  Medscape Medical News, November 2018
• Alert FDA Approves New Drug for Traveler's Diarrhea (Aemcolo) Aemcolo (rifamycin) is indicated to treat adults with travelers' diarrhea caused by noninvasive strains of E. coli and not complicated by fever or blood in the stool.
  FDA Approvals, November 2018
• Alert EMA Curtails Use of Fluoroquinolone, Quinolone Antibiotics The occurrence of disabling and potentially permanent side effects associated with quinolone and fluoroquinolone antibiotics has led the European Medicines Agency (EMA) to restrict or suspend their use.
  News Alerts, November 2018
• Alert EMA Panel Backs First Oral-Only Drug for Deadly Disease Fexinidazole is for the treatment of human African trypanosomiasis caused by Trypanosoma brucei gambiense in adults and children aged 6 years and older.
  International Approvals, November 2018
• Alert FDA Clears First Ebola Fingerstick Test With Portable Reader The DPP Ebola Antigen System is the second Ebola rapid antigen fingerstick test granted emergency use authorization and the first that uses a portable battery-operated reader.
  FDA Approvals, November 2018
• Alert Medicare Plans to Phase in Changes for Office-Visit Payments CMS delays the start of a controversial E&M payment change but remains committed to collapsing what's now a five-level coding system.
  Medscape Medical News, November 2018
• Alert CDC Panel Backs Routine Hepatitis A Shots for Homeless ACIP seeks to address outbreaks of the liver-damaging infection in the United States. The panel also tweaked the adult, child, and teen vaccination schedules.
  News Alerts, October 2018
• Alert Cell-Based Quadrivalent Flu Vaccine Recommended by EMA Panel The EMA CHMP has recommended granting marketing authorization for Flucelvax Tetra (Seqirus Netherlands BV), a quadrivalent cell-based influenza vaccine.
  International Approvals, October 2018
• Alert EU Panel Recommends Marketing Authorization for Dengue Vaccine The EMA CHMP has recommended marketing authorization for a dengue tetravalent vaccine against dengue virus serotypes 1, 2, 3, and 4.
  International Approvals, October 2018
• Alert FDA Approves Revcovi for Adenosine Deaminase SCID The US Food and Drug Administration has approved elapegademase-lvlr for the treatment of adults and children with adenosine deaminase severe combined immune deficiency.
  FDA Approvals, October 2018
• Alert FDA Expands Gardasil to Include Adults Up to Age 45 The expanded age range for Gardasil 9 is an important opportunity to help prevent HPV-related diseases and cancers in a broader age range, the FDA said.
  FDA Approvals, October 2018
• Alert PRAC Again Warns Against Dolutegravir Use During Pregnancy The European Medicines Agency has confirmed its earlier precaution regarding the use of dolutegravir in women who are or who could become pregnant; it expects to make final recommendations next year.
  News Alerts, October 2018
• Alert PRAC Recommends Restrictions on Fluoroquinolone, Quinolones The new restrictions follow a review of rare but disabling and potentially long-lasting side effects, mainly involving muscles, tendons, bones, and the nervous system.
  News Alerts, October 2018
• Alert FDA Clears Omadacycline (Nuzyra) for Two Infections Omadacycline is a modernized tetracycline with broad-spectrum activity that is designed to overcome tetracycline resistance.
  FDA Approvals, October 2018
• Alert FDA Approves Sarecycline for Moderate to Severe Acne The FDA has approved sarecycline (Seysara, Almirall) for patients aged 9 years and older with inflammatory lesions associated with non-nodular moderate to severe acne vulgaris.
  FDA Approvals, October 2018
• Alert EMA Panel Backs Two New HIV Drugs Pifeltro contains doravirine, a new nonnucleoside reverse transcriptase inhibitor, and Delstrigo is a fixed-dose combination of doravirine, lamivudine, and tenofovir disoproxil fumarate.
  International Approvals, September 2018
• Alert New Antibiotics for Europe: CHMP Likes Vabomere, EC Clears Xerava Vabomere combines meropenem and vaborbactam for treatment of complicated UTIs and other infections; Xerava (eravacycline) is for complicated intra-abdominal infections.
  International Approvals, September 2018
• Alert Clinicians Advised to Prep for 'Huge Challenge' From Florence Disaster aid organization urges clinicians to reach out to fragile patients, as hospitals and aid organizations prepare for what one governor says will be a 'marathon, not a sprint.'
  Medscape Medical News, September 2018